68Ga-NI-FAPI PET/CT: First-in-human Study
NCT06688305
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Malignant Neoplasm
Interventions
DRUG:
68Ga-NI-FAPI
Sponsor
First Affiliated Hospital of Fujian Medical University